![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Geng, Xiaocong; Babayeva, Lamiya; Walch, Axel; Aubele, Michaela; Gross, Eva; Kiechle, Marion; Bronger, Holger; Dreyer, Tobias; Magdolen, Viktor und Dorn, Julia
(2020):
High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients.
In: American Journal of Cancer Research, Bd. 10, Nr. 6: S. 1785-1792
Panoutsopoulou, Konstantina; Avgeris, Margaritis; Magkou, Paraskevi; Mavridis, Konstantinos; Dreyer, Tobias; Dorn, Julia; Obermayr, Eva; Reinthaller, Alexander; Michaelidou, Kleita; Mahner, Sven; Vergote, Ignace; Loverix, Liselore; Braicu, Ioana; Sehouli, Jalid; Zeillinger, Robert; Magdolen, Viktor und Scorilas, Andreas
(2020):
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
In: International Journal of Cancer, Bd. 147, Nr. 12: S. 3560-3573
Panoutsopoulou, Konstantina; Avgeris, Margaritis; Mavridis, Konstantinos; Dreyer, Tobias; Dorn, Julia; Obermayr, Eva; Reinthaller, Alexander; Michaelidou, Kleita; Mahner, Sven; Vergote, Ignace; Vanderstichele, Adriaan; Braicu, Ioana; Sehouli, Jalid; Zeillinger, Robert; Magdolen, Viktor und Scorilas, Andreas
(2020):
miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.
In: Carcinogenesis, Bd. 41, Nr. 4: S. 442-451
Absmaier, Magdalena; Napieralski, Rudolf; Schuster, Tibor; Aubele, Michaela; Walch, Axel; Magdolen, Viktor; Dorn, Julia; Gross, Eva; Harbeck, Nadia; Noske, Aurelia; Kiechle, Marion und Schmitt, Manfred
(2018):
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
In: International Journal of Oncology, Bd. 52, Nr. 3: S. 755-767
Harbeck, Nadia; Saupe, Steffen; Jäger, Elke; Schmidt, Marcus; Kreienberg, Rolf; Müller, Lothar; Otremba, Burkhard Jörg; Waldenmaier, Dirk; Dorn, Julia; Warm, Mathias; Scholz, Michael; Untch, Michael; Wit, Maike de; Barinoff, Jana; Lück, Hans-Joachim; Harter, Philipp; Augustin, Doris; Harnett, Paul; Beckmann, Matthias W. und Al-Batran, Salah-Eddin
(2017):
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
In: Breast Cancer Research and Treatment, Bd. 161, Nr. 1: S. 63-72
[PDF, 711kB]